Riskpilot← Back to searchSign inGet full accessTadavi AB
ABActiveOrg 5592286859Klippervägen 11 CMedical specialists activities · NACE 8622Est. 20190 employees
Revenue 2025
SEK 759K
-12% vs 2024
EBITDA margin
-6.6%
-128% vs 2024
Equity ratio
10.8%
Financial strength
Net profit 2025
SEK -20K
-118% vs 2024
| Revenue | SEK 759K | -12% |
| EBITDA | SEK -50K | -128% |
| Net profit | SEK -20K | -118% |
| Total assets | SEK 284K | -44% |
| Equity | SEK 31K | -81% |
| Employees | 0 | — |
Legal name
Tadavi AB
Org number
5592286859
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
27 november 2019
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva konsultverksamhet, utbildning samt bemanning inom hälso- sjuk- och tandvård och skönhetsvård samt handel med värdepapper, metaller och fastighetsegendom samt förenlig verksamhet.
Address
Klippervägen 11 C
Email
info@tadavi.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 169 | 181 | 841 | 859 | 759 |
| Staff expenses | — | — | — | −420 | −487 |
| EBITDA | 18 | 52 | 108 | 179 | −50 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | 18 | 52 | 108 | 179 | −50 |
| Net financials | — | — | — | −4 | −1 |
| Profit before tax | 18 | 41 | 77 | 145 | −20 |
| Tax | −0 | −7 | −19 | −34 | — |
| Net profit | 18 | 34 | 58 | 111 | −20 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 81 | 144 | 395 | 503 | 284 |
| Equity | 43 | 77 | 135 | 161 | 31 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 38 | 56 | 218 | 270 | 212 |
| Total debt | 38 | 56 | 218 | 270 | 212 |
EBITDA margin
-6.6%
This company
15.8%
Market median
-142% vs market
20212025
Equity ratio
10.8%
This company
38.2%
Market median
-72% vs market
20212025
Return on equity
-65.2%
This company
18.4%
Market median
-454% vs market
20212025
Net profit margin
-2.6%
This company
8.1%
Market median
-132% vs market
20212025
Asset turnover
2.67×
This company
1.12×
Market median
+138% vs market
20212025
Debt / equity
8.25×
This company
0.62×
Market median
-1231% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-09-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MM Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Tadavi AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Munir Mustafa Amin | Deputy Chief Executive Officer | 0 companies |
| Dana Misaghi | Deputy Board Member | 0 companies |
| Paricher Tagik | Chairman | 0 companies |